Cancer drug shortages expose Europe’s dangerous dependence on a few global suppliers

EU PERSPECTIVES - Hospitals across Europe are running low on two vital cancer medicines, forcing doctors to make difficult choices about who gets treatment first. Regulators warn that these shortages could last through 2026. Read more

Limited supply of critical chemotherapy drugs is putting patient care under pressure / Photo: Unsplash